Abstract
The hypothesis of a cholinergic-/aminergic transmitter imbalance as the cause of manic-depressive disorders, formulated by Janowsky and coworkers (Janowsky et al. 1972; Janowsky and Risch 1986), is based on the observation that biological systems, such as heart rate, blood pressure, body temperature, and extrapyramidal system, are regulated by at least two transmitter systems in reciprocal interaction. It seemed reasonable to extend the amine deficiency hypothesis of depression to an imbalance model between the aminergic and cholinergic central transmitter systems (Berger 1985, 1987).
Supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 258, Teilprojekt B/M).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ansseau M, Scheyvaerts M, Doumont A, Poirrier R, Legros JJ, Franck G (1984) Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study. Psychiatry Res 12: 261–272
Ansseau M, Frenckell R von, Cerfontaine JL, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros JJ (1987) Neuroendocrine evaluation in catecholaminergic neurotrans-mission in mania. Psychiatry Res 22: 193–206
Beersma DGM, Daan S, Hoofdakker RH van den (1984) Sleep structure in depression. Exp Brain Res 8: 285–296
Berger M (1985) Vergleichende psychobiologische Untersuchungen bei enogenen und neurotischen Depressionen. Thesis, University of Munich
Berger M (1987) Schlaf-EEG Studien zum aminerg-cholinergen Imbalance-Modell depressiver Erkrankungen. In: Angst J, Gastpar M (eds) Depression - Schlaf - Traum. Panscientia, Hedingen, Zürich, pp 38–51
Berger M, Doerr P, Lund R, Bronisch T, Zerssen D von (1982) Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry 17: 1217–1242
Berger M, Lund R, Bronisch T, Zerssen D von (1983) REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 10:113– 123
Berger M, Pirke KM, Doerr P, Krieg JC, Zerssen D von (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145: 372–382
Berger M, Riemann D, Höchli D, Spiegel R (1989) The cholinergic REM induction test with RS 86: state or trait marker of depression? Arch Gen Psychiatry 46: 421–428
Bunney WE Jr, Goodwin FK, Murphy DL, House GM, Gordon EK (1972) The “switch process” in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry 27: 304–309
Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to Clonidine in patients with endogenous depression. Br J Psychiatry 138: 51–55
Delitala G, Maioli M, Pacifico A, Brianda S, Palermo M, Mannelli M (1983) Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab 57: 1145–1149
Doerr P, Berger M (1983) Physostigmine induced escape from dexamethasone suppression in normal adults. Biol Psychiatry 18: 261–267
Doerr P, von Zerssen D, Fischler M, Schulz H (1979) Relationship between mood changes and adrenal cortical activity in a patient with a 48-hour unipolar depressive cycle. J Affective Disord 1: 93–104
Gilbert P (1984) Depression: from psychology to brain state. Lawrence Erlbaum, Hillsdale
Hobson JA, Steriade M (1986) Neuronal basis of behavioural state control. In: Mountcastle VB, Bloom FE, Geiger SR (eds) Intrinsic regulatory systems of the brain. American Physiological Society Bethesda, pp 701-823 (Handbook of physiology, vol 4 )
Hobson JA, McCarley RW, McKenna TM (1976) Cellular evidence bearing on the pontine brainstem hypothesis of desynchronized sleep control. Prog Neurobiol 6: 280–285
Hoehe M, Valido G, Matussek, N (1988) Growth hormone, noradrenaline, blood pressure and Cortisol responses to Clonidine in healthy male volunteers: dose-response relations and reproducibility. Psychoneuroendocrinology 13: 409–418
Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ (1989) Electroen- cephalographic sleep in mania. Arch Gen Psychiatry 45: 267–273
Janowsky DS, Risch SC (1986) Adrenergic-cholinergic balance and affective disorders. In: Rush AJ, Altshuler KZ (eds) Depression - basic mechanisms, diagnosis, and treatment. Guilford, New York, pp 84–101
Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic noradrenergic hypothesis of mania and depression. Lancet 2: 632–635
Janowsky DS, Risch SC, Jedd LL, Parker DC, Kalin NH, Huey LJ (1983) Behavioral and neuroendocrine effects of physostigmine in affective disorder patients. In: Clayton PJ, Barret JE (eds) Treatment of depression: old controversies and new approaches. Raven, New York, pp 61–74
Krieg JC, Berger M (1986) Cholinergic influence on manic symptoms. Clin Neuropharmacol 9: 544–546
Krieg JC, Bossert S, Pirke KM, Zerssen D von, Berger M (1987) The influence of the muscarinic agonist RS 86 on the Cortisol system. Biol Psychiatry 2: 573–582
Kupfer DJ, Henninger GR (1972) REM activity as a correlate of mood changes throughout the night. Arch Gen Psychiat 27: 368–373
Lauer C, Zulley J, Krieg JC, Riemann D, Berger M (1988) EEG sleep and the cholinergic REM induction test in anorexia and bulimic patients. Psychiatry Res 26: 171–181
Matussek N (1988) Catecholamines and mood: neuroendocrine aspects. In: Granten D, Pfaff D, Fuxe K (eds) Current topics in neuroendocrinology, vol 8, pp 141–182, Springer, Berlin Heidelberg New York
Matussek N, Ackenheil M, Hippius H, Müller F, Schröder HT, Schultes H, Wasilewski B (1980) Effect of Clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2: 25–36
McCarley RW (1982) REM sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 139:565–570
Palacios JM, Bollinger G, Closse A, Enz A, Gmelin G, Malanowski J (1986) The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro(4,5-decan- 1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist. Eur J Pharmacol 125: 45–62
Post RM (1987) Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 567–576
Rechtschaffen A, Kales A (1968) Manual of standardized terminology techniques and scoring system for sleep stages of human subjects. National Institute of Health Publications 204. US Government Printing Office, Washington DC
Riemann D, Berger M (1989) EEG sleep in depression and remission and the cholinergic REM induction response to RS 86. Neuropsychopharmacology 2: 145–152
Riemann D, Joy D, Höchli D, Lauer C, Zulley J, Berger M (1988) Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects. Psychiatry Res 24: 137–147
Siever LJ, Uhde TW (1984) New studies and perspectives on the noradrenergic receptor system in depression. Effects of the alpha2-adrenergic agonist Clonidine. Biol Psychiatry 19: 131–156
Sitaram N, Moore AM, Gillin JC (1978 a) Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274: 490–492
Sitaram N, Moore AM, Gillin JC (1978 b) Induction and resetting of REM sleep rhythm in normal man by arecholine: blockade by scopolamine. Sleep 1: 83–90
Sitaram N, Moore AM, Gillin JC (1979) Scopolamine induced muscarinic supersensitivity in normal man: changes in sleep. Psychiatry Res 1: 9–16
Sitaram N, Gillin JC, Bunney WE (1984) Cholinergic and catecholaminergic receptor sensitivity in affective illness: Strategy and theory. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 629–651
Spiegel R (1984) Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res 11: 1–13
Van Loon GR (1973) Catecholamines and ACTH secretion. In: Ganong WF, Martin L (eds) Frontiers in neuroendocrinology. Oxford University Press, New York, pp 209–247
Vogel GW, Vogel E, McAbee RS, Thurmond A J (1980) Improvement of depression by REM sleep deprivation. Arch Gen Psychiatry 37: 247–253
Zerssen D von (1986) Clinical self-rating scales (CSRS) of the Munich psychiatry information system (PSYCHIS München). In: Sartorius N, Ban T (eds) Assessment of depression. Springer, Berlin Heidelberg New York
Zerssen D von, Lund R, Doerr P, Fischler M, Emrich HM, Ploog D (1979) 48-hour-cycles of depression and their biological concomitants with and without “Zeitgebers”. A case report. In: Saletu B, Berner P, Hollister L (eds) Neuropsychopharmacology. Pergamon, Oxford, pp 233–245
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Berger, M., Fleckenstein, P., Riemann, D., Müller, W.E. (1990). Experimental Approaches for Testing the Cholinergic-Noradrenergic Imbalance Hypothesis of Affective Disorders. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-74034-3_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74036-7
Online ISBN: 978-3-642-74034-3
eBook Packages: Springer Book Archive